echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > East China's 2 billion varieties will be approved. Hengrui and Hisun have begun to seize the market

    East China's 2 billion varieties will be approved. Hengrui and Hisun have begun to seize the market

    • Last Update: 2021-05-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    East China's four types of generic listing applications for letrozole tablets have entered the "under review" stage, and good news is expected in the near future.


    Figure 1: The registration progress of Letrozole tablets in East China

    Source: NMPA official website

    Figure 2: The competitive landscape of letrozole tablets

    Source: Mi Nei.


    According to data from Meinnet.


    In recent years, East China has begun to exert efforts in the field of endocrine therapy drugs.


    Source: Minet database

    The review data statistics are as of May 10, if there are any errors or omissions, please correct me.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.